SG/CALL/ELI LILLY & CO/1000/0.1/19.12.25 | Real-time Bid/Ask 13:42:00 13/05/2024 BST | ||
| 6.16 EUR / 6.23 EUR | -4.69% |
|
| Current month | +11.68% | ||
| 1 month | -2.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/24 | 6.18 | -4.92% | 0 |
| 10/05/24 | 6.5 | -2.40% | 0 |
| 09/05/24 | 6.66 | -1.62% | 0 |
| 08/05/24 | 6.77 | +10.08% | 0 |
| 07/05/24 | 6.15 | +17.82% | 0 |
Delayed Quote Börse Stuttgart
Last update May 13, 2024 at 08:24 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SU92Y3 |
| ISIN | DE000SU92Y39 |
| Date issued | 29/02/2024 |
| Strike | 1,000 $ |
| Maturity | 19/12/2025 (585 Days) |
| Parity | 10 : 1 |
| Emission price | 7.02 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.37 € |
|---|---|
| Lowest since issue | 5.22 € |
| Delta | 0.38x |
| Omega | 4.324 |
| Premium | 40.37x |
| Gearing | 11.38x |
| Moneyness | 0.7600 |
| Difference Strike | 240 $ |
| Difference Strike % | +24.00% |
| Spread | 0.07 € |
| Spread % | 1.13% |
| Theoretical value | 6.185 |
| Implied Volatility | 32.33 % |
| Total Loss Probability | 75.91 % |
| Intrinsic value | 0.000000 |
| Present value | 6.185 |
| Break even | 1,066.78 € |
| Theta | -0.08x |
| Vega | 0.34x |
| Rho | 0.33x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
760
USD
Average target price
850.4
USD
Spread / Average Target
+11.90%
- Stock Market
- Warrants
- Warrant
